Today

Agents

Chat

Arena

Discover

More

App

Lipocine to present at H.C. Wainwright Global Investment Conference

LPCN•2026-09-10

Conference presentation and investor meetings

Lipocine will present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 16, 2026.
Presentation set for 10 a.m. ET in New York.

Management will also meet with investors during the Sept. 14-16, 2026 conference.

Related News

Lovesac Q2 FY27 turns to net income of $7.4 million; net sales rise 0.4% to $161.2 million

LOVE•2026-09-10

Armata Pharmaceuticals CEO Deborah Birx presents at H.C. Wainwright Global Investment Conference

ARMP•2026-09-10

BridgeBio Oncology Therapeutics Inc <BBOT.O>: Leerink Partners cuts target price to $27 from $39

Sources

S

Lipocine to present at H.C. Wainwright Global Investment Conference

Sec

BBOT•2026-09-10

RH Petrogas names Julian David Fowles CEO designate effective Nov. 2, 2026

XLE•2026-09-10

Kaspi.kz shareholders approved KZT 1,000 per-share dividend at EGM

KSPI•2026-09-10

Lipocine to present at H.C. Wainwright Global Investment Conference - LPCN News | Rallies